Indo National acquires 0.79% stake in Medcuore for ₹49.9 lakh

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Indo National Limited acquired an additional 0.79% stake in Medcuore Medical Solutions Private Ltd for ₹49,89,880.
  • The total shareholding in MMSPL now stands at 63.07%, with shares purchased at ₹14,056 each.
  • Medcuore reported a turnover of ₹1.45 crore in FY26, a significant increase from ₹35.41 lakh in FY25.
  • The acquisition is aimed at business expansion and profit generation, with no related party interests involved.
powered bylight_fuzz_icon
52745133

*this image is generated using AI for illustrative purposes only.

Indo National Limited has invested ₹49,89,880 to acquire an additional 0.79% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL). This transaction raises the company's aggregate shareholding in the medical device manufacturer to 63.07%.

The investment was made by way of subscription to equity shares at a price of ₹14,056 per share for 355 shares. The valuation was based on a report issued by a registered valuer dated August 21, 2026. The acquisition does not constitute a related party transaction, and no promoter group entities hold any interest in MMSPL.

Strategic Rationale and Target Profile

MMSPL is engaged in the manufacturing, distribution, and service provision of air monitoring systems and air purifiers. Indo National stated that the objective of this additional investment is to facilitate business growth, generate revenue, and earn profits through the expansion of operations. The target entity operates exclusively within India.

The company indicated that the indicative time period for the completion of the acquisition extends up to FY28. No governmental or regulatory approvals are required for this specific transaction.

Financial Performance of Medcuore

Medcuore Medical Solutions Private Ltd was incorporated on June 7, 2020. The filing discloses the turnover figures for the last three fiscal years, highlighting significant volatility in revenue generation.

Fiscal Year Turnover
FY26 ₹1,45,60,000
FY25 ₹35,41,484
FY24 ₹47,68,000

What the Numbers Show

The disclosed turnover data reveals a sharp divergence in performance between FY25 and FY26. Revenue surged from ₹35.41 lakh in FY25 to ₹1.45 crore in FY26, marking a substantial year-on-year expansion. However, this recent growth contrasts with the FY24 figure of ₹47.68 lakh, indicating that the FY25 dip was likely a temporary contraction rather than a long-term downward trend. The current valuation implies confidence in the sustained upward trajectory observed in the most recent fiscal year.

Historical Stock Returns for Indo National

1 Day5 Days1 Month6 Months1 Year5 Years
+1.37%-1.79%-2.83%+11.59%-29.12%-34.30%

How will Indo National integrate Medcuore's air purification product lines with its existing plumbing and building materials distribution network to drive cross-selling opportunities?

What specific capital expenditure plans are in place to scale Medcuore's manufacturing capacity to sustain the triple-digit revenue growth observed in FY26?

Given the volatile historical turnover, what key performance indicators or milestones must Medcuore meet by FY28 to justify the current valuation multiple?

Indo National 53rd AGM: all 5 resolutions pass, ₹3.75 dividend approved

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Indo National Ltd's 53rd AGM, held September 28, 2026, saw all five resolutions pass with requisite majority
  • A final dividend of ₹3.75 per equity share (75% of face value of ₹5 each) for FY26 was approved
  • Total votes polled stood at 4,558,097, representing 60.77% of 7,500,000 outstanding shares
  • The special resolution on commission to Non-Executive Independent Directors received 92.49% votes in favour
  • Scrutinizer M. Damodaran of M Damodaran & Associates LLP confirmed zero abstained or invalid votes across all resolutions
powered bylight_fuzz_icon
52150632

*this image is generated using AI for illustrative purposes only.

Indo National Ltd declared a final dividend of ₹3.75 per equity share for FY26 at its 53rd Annual General Meeting held on September 28, 2026, with all five resolutions passing with requisite majority.

The AGM was conducted via Video Conferencing at 3:00 pm, concluding at 3:43 pm. A total of 58 shareholders attended through video conferencing, comprising 2 from the promoter and promoter group and 56 from the public. No shareholders were present in person or through proxy. The record date for voting eligibility was September 21, 2026, with 14,582 shareholders on the register. Remote e-voting ran from September 25, 2026 at 9:00 am to September 27, 2026 at 5:00 pm, with e-voting at the AGM facilitated through Central Depository Services (India) Limited.

Key resolutions passed

Shareholders approved five resolutions spanning ordinary and special business:

  • Adoption of standalone and consolidated financial statements for FY26.
  • Declaration of dividend at ₹3.75 per equity share (75% of face value of ₹5 each).
  • Re-appointment of Ms. Suneeta Reddy (DIN: 00001873) as Director liable to retire by rotation.
  • Approval of remuneration payable to Cost Auditor M/s. B. Thulasiram & Co., Cost Accountant, Chennai (Firm Registration No. 003539) for the financial year ending March 31, 2027.
  • Payment of commission/remuneration to Non-Executive Independent Directors (Special Resolution).

Voting results summary

The scrutinizer's report, prepared by M. Damodaran, Managing Partner of M Damodaran & Associates LLP, confirmed all five resolutions passed. The consolidated voting data across 7,500,000 total shares showed 4,558,097 votes polled, representing 60.77% of outstanding shares.

Resolution Type Votes in favour Votes against % in favour
1. Adoption of financial statements Ordinary 4,240,870 317,227 93.04%
2. Declaration of dividend Ordinary 4,240,870 317,227 93.04%
3. Re-appointment of Ms. Suneeta Reddy Ordinary 4,240,864 317,233 93.04%
4. Remuneration to Cost Auditor Ordinary 4,240,835 317,262 93.04%
5. Commission to Independent Directors Special 4,215,615 342,482 92.49%

For Resolutions 1 through 4, the promoter and promoter group cast 4,161,516 votes in favour via e-voting, representing 84.91% of their 4,901,366 shares held. Public non-institutional shareholders polled 396,581 votes across these resolutions. There were zero abstained or invalid votes recorded for any resolution.

Meeting attendance and governance

Item Detail
Total shareholders on record date 14,582
Attendees via VC (promoter group) 2
Attendees via VC (public) 56
Meeting duration 3:00 pm to 3:43 pm
Dividend rate ₹3.75 per share
Total resolutions passed 5

Ms. Deepa Seshadri, Chairman and Independent Director, presided over the meeting. The Company Secretary confirmed that the Statutory Auditors' report and Secretarial Audit report for FY26 contained no qualifications or adverse remarks. Key managerial personnel present included CEO Pavan Kumar BVS and CFO S.R. Aravind Kumar. The statutory auditor R. Ravishankar was also in attendance.

Directorship updates

The re-appointment of Ms. Suneeta Reddy as Director was ratified by members. She joins the board alongside Managing Director P. Dwaraknath Reddy, Independent Director Murali Subramaniam, and Director BLN Prasad. The scrutinizer's report was submitted to stock exchanges by Company Secretary J. Srinivasan on September 29, 2026, in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Indo National

1 Day5 Days1 Month6 Months1 Year5 Years
+1.37%-1.79%-2.83%+11.59%-29.12%-34.30%

How will the ₹3.75 dividend payout impact Indo National's cash reserves and capital expenditure plans for FY27?

What strategic initiatives are expected to drive revenue growth following the approval of the FY26 financial statements?

How might the re-appointment of Ms. Suneeta Reddy influence the company's corporate governance standards and board dynamics in the coming year?

More News on Indo National

1 Year Returns:-29.12%